BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11934258)

  • 21. Characterization of bradykinin receptors in peripheral organs.
    Rhaleb NE; Rouissi N; Drapeau G; Jukic D; Regoli D
    Can J Physiol Pharmacol; 1991 Jul; 69(7):938-43. PubMed ID: 1720068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bradykinin in the neonatal renal effects of angiotensin converting enzyme inhibition.
    Tóth-Heyn P; Mosig D; Guignard JP
    Life Sci; 1998; 62(4):309-18. PubMed ID: 9450502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinin receptors and angiotensin converting enzyme in rabbits basilar arteries.
    Whalley ET; Fritz H; Geiger R
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):296-301. PubMed ID: 6141533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of kinin receptors by bioassays.
    Gobeil F; Regoli D
    Braz J Med Biol Res; 1994 Aug; 27(8):1781-91. PubMed ID: 7749368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of bradykinin and resensitization of its B2 receptor.
    Marcic B; Deddish PA; Jackman HL; Erdös EG
    Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
    Rizzi A; Calò G; Amadesi S; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):662-70. PubMed ID: 9402047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonists for kinin B1 and B2 receptors in the mouse.
    Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.
    Drummond GR; Cocks TM
    Br J Pharmacol; 1995 Nov; 116(5):2473-81. PubMed ID: 8581287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum.
    Minshall RD; Nedumgottil SJ; Igić R; Erdös EG; Rabito SF
    Peptides; 2000 Aug; 21(8):1257-64. PubMed ID: 11035213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
    Gobeil F; Montagne M; Inamura N; Regoli D
    Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?
    Fortin JP; Gobeil F; Adam A; Regoli D; Marceau F
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H277-82. PubMed ID: 12649080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors for kinins in the human isolated umbilical vein.
    Gobeil F; Pheng LH; Badini I; Nguyen-Le XK; Pizard A; Rizzi A; Blouin D; Regoli D
    Br J Pharmacol; 1996 May; 118(2):289-94. PubMed ID: 8735629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
    Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
    Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
    Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens.
    Maas J; Rae GA; Huidobro-Toro JP; Calixto JB
    Br J Pharmacol; 1995 Apr; 114(7):1471-7. PubMed ID: 7606350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.
    Marceau F; Levesque L; Drapeau G; Rioux F; Salvino JM; Wolfe HR; Seoane PR; Sawutz DG
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1136-43. PubMed ID: 8014858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B; de Vries R; Saxena PR; Danser AH
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
    Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
    Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
    Lembeck F; Griesbacher T; Eckhardt M
    Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.